Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (508)

Company Market Cap Price
NCPL Netcapital Inc.
Online brokerage/marketplace-like access for capital raises and investor participation.
$4.36M
$2.08
+4.27%
CWD CaliberCos Inc.
CaliberCos operates as an alternative asset manager focused on real estate and related assets.
$3.85M
$2.82
-4.73%
SBET SharpLink Gaming Ltd.
Asset management/brokerage exposure via ETH treasury and investment plans.
$3.21M
$13.16
-3.31%
GSIW Garden Stage Limited Ordinary Shares
Company provides asset management services through its subsidiary IWAML, managing client assets.
$2.48M
$0.15
-5.99%
ELAB PMGC Holdings Inc.
PMGC Capital functions as the company's asset management and brokerage arm, coordinating diversified investments and capital allocation.
$2.29M
$5.87
+0.43%
BTOG Bit Origin Limited
The Dogecoin treasury strategy implies an asset management/function focused on digital asset investments.
$2.06M
$0.36
-1.27%
← Previous
1 ... 4 5 6
Next →
Showing page 6 of 6 (508 total stocks)

Loading company comparison...

Loading research report...

CWD CaliberCos Inc.

CaliberCos Regains Nasdaq Stockholders’ Equity Compliance

Oct 23, 2025
SBET SharpLink Gaming Ltd.

T‑REX Launches 2X Leveraged ETF for SharpLink Gaming

Oct 22, 2025
CWD CaliberCos Inc.

CaliberCos Announces Preliminary Q3 2025 Results, Highlights Strengthened Balance Sheet

Oct 09, 2025
CWD CaliberCos Inc.

CaliberCos Announces Partnership to Deploy EV Charging Infrastructure Across Portfolio

Oct 07, 2025
CWD CaliberCos Inc.

CaliberCos Appoints Blake Janover to Crypto Advisory Board

Oct 01, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Completes Phase II of AI Development Program with YuvaBio

Sep 04, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Announces Anticipated 1-for-3.5 Reverse Stock Split

Aug 28, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Closes $1.67 Million Warrant Inducement with Institutional Investors

Aug 25, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Announces $1.67 Million in Gross Proceeds from Warrant Inducement

Aug 22, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Files Quarterly Report on Form 10-Q for Q2 2025

Aug 13, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Terminates LOI for Electronics Manufacturer, Refocuses on CNC Precision Manufacturing

Jul 30, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Completes Acquisition of CNC Machining Company AGA Precision Systems LLC

Jul 18, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging

Jul 10, 2025
ELAB PMGC Holdings Inc.

PMGC Capital Urges Alaunos Therapeutics to Accept Financing Term Sheet from Leading Wall Street Bank

Jun 18, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Initiates Phase II of AI Development Program with YuvaBio for Obesity and Cardiometabolic Diseases

Jun 17, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Signs LOI to Acquire Profitable CNC Aerospace Manufacturer with $4.5 Million Annual Revenue

Jun 24, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Signs LOI to Acquire Profitable U.S.-Based Electronics Manufacturing Company

Jun 09, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Completes Phase I Strategic Review for EL-22 Obesity Drug Candidate

May 22, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Files Q1 2025 Quarterly Report, Reports Widened Net Loss

May 14, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Signs Binding Term Sheet for Exclusive Global Animal Health Licensing of EL-22

May 13, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32

Apr 29, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Receives Positive FDA Response for EL-22 Phase 2 Clinical Trial IND Submission

Apr 24, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Signs LOI to Acquire Profitable U.S.-Based Custom IT Packaging Company

Apr 16, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Partners with Yuva Biosciences to Develop AI-Powered Therapies

Apr 10, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Files Annual Report on Form 10-K for Fiscal Year Ended December 31, 2024

Mar 28, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Expands Licensing Rights to Animal Health Market for EL-22 and EL-32

Mar 27, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Closes $1.48 Million Registered Direct Offering

Mar 24, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering

Mar 21, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Schedules Pre-IND Meeting with FDA for EL-22 Obesity Therapy

Mar 10, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Announces 1-for-7 Reverse Stock Split to Maintain Nasdaq Listing Compliance

Mar 06, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Expands M&A Efforts Through Strategic Sponsorship of TCA Venture Group

Feb 27, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Highlights Strong Capital Position: No Debt and Fully Funded

Feb 26, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Submits Pre-IND Meeting Request to FDA for EL-22 Obesity Therapy

Feb 18, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Provides Positive Updates on Obesity Drug Candidates EL-22 and EL-32

Feb 04, 2025
ELAB PMGC Holdings Inc.

PMGC Capital Begins Building Portfolio with Strategic Investments in Uranium Energy and Fire Prevention

Jan 31, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences Signs Agreement for Preclinical Mouse Study of EL-32 Obesity Therapy

Jan 30, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Closes $1.92 Million Warrant Inducement with Institutional Investors

Jan 28, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement

Jan 27, 2025
ELAB PMGC Holdings Inc.

Northstrive Biosciences to Present Breakthrough Muscle Preservation Asset EL-22 at UCLA Obesity Symposium

Jan 24, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture

Jan 16, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries

Jan 15, 2025
ELAB PMGC Holdings Inc.

PMGC Holdings Enters Definitive Agreement to Divest Elevai Skincare to Carmell Corporation

Jan 02, 2025
ELAB PMGC Holdings Inc.

Elevai Labs Inc. Completes Name Change to PMGC Holdings Inc. and Redomiciles to Nevada

Dec 20, 2024
ELAB PMGC Holdings Inc.

Elevai Biosciences Announces FDA Regulatory Pathway for EL-22 Obesity Therapy

Dec 09, 2024
ELAB PMGC Holdings Inc.

Elevai Skincare Launches S-Series Root Renewal System, Entering Hair Care Market

Dec 06, 2024
ELAB PMGC Holdings Inc.

Elevai Skincare Division Achieves Record-Breaking Sales Month in 2024

Dec 04, 2024
ELAB PMGC Holdings Inc.

Elevai Labs Announces 1-for-200 Reverse Stock Split to Maintain Nasdaq Listing

Nov 22, 2024
ELAB PMGC Holdings Inc.

Elevai Labs Reports Third Fiscal Quarter 2024 Financial Results

Nov 14, 2024
ELAB PMGC Holdings Inc.

Elevai Labs Extends Exchange Offer for Common Stock to Series B Preferred Stock

Nov 04, 2024
ELAB PMGC Holdings Inc.

Elevai Biosciences Engages CRO to Support Regulatory Planning for EL-22 IND Application

Oct 22, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks